Table 1. Clinical characteristics of the study subjects at the first examination.
| Parameter | |
|---|---|
| Number | 2437 |
| Age (y.o.) | 46±9 |
| BMI (kg/m 2 ) | 24.0±3 |
| Alcohol intake, ethanol g/day | 9.4±6.0 |
| SBP (mm Hg) | 123±15 |
| DBP (mm Hg) | 76±11 |
| Pulse rate (bpm) | 69±10 |
| Hb (g/L) | 149±10 |
| PLT (10 9 /L) | 230±48 |
| AST (U/L) | 23±9 |
| ALT (U/L) | 27±17 |
| GGT (U/L) | 52±46 |
| TC (mmol/L) | 5.4±0.9 |
| HDL (mmol/L) | 1.6±0.4 |
| TG (mmol/L) | 1.4±1.2 |
| FPG (mmol/L) | 5.1±0.7 |
| Serum creatinine (µmol/L) | 76±10 |
| Serum NT- pro BNP (pg/ml) | 24±20 |
| median (IQR) | 18 (8-31) |
| baPWV (cm/sec) | 1305±195 |
| r-AI (%) | 70±13 |
| FIB-4 | 1.0±0.5 |
| FLI | 35±25 |
| Medication history | |
| Hypertension: number of subjects (%) | 263 (11) |
| Dyslipidemia: number of subjects (%) | 98 (4) |
| Diabetes mellitus: number of subjects (%) | 67 (3) |
Abbreviations: BMI: Body mass index; Alcohol intake, ethanol g/day: Alcohol intake per day converted into ethanol equivalent; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; Hb: Hemoglobin; PLT: Platelet count; AST: Serum aspartate aminotransferase; ALT: Serum alanine aminotransferase; GGT: Serum gamma-glutamyl-transferase; TC: Serum total cholesterol; HDL: Serum high-density lipoprotein cholesterol; TG: Serum triglycerides; FPG: Fasting plasma glucose; NT-proBNP: Serum N-terminal of B-type natriuretic peptide; baPWV: brachial-ankle pulse wave velocity; r-AI : Radial augmentation index; FIB-4: Fibrosis 4 score; FLI: Fatty liver index;